Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative REGN - Regeneron Pharmaceuticals, Inc.
2.95 B
LAST VALUE
18.16%
2 YEAR CAGR
10.00%
5 YEAR CAGR
19.33%
10 YEAR CAGR